SCHEMBL2223299

SCHEMBL2223299

CN1CCC(Nc2cc(S(=O)(=O)c3c[nH]c4ccc(C(F)(F)F)cc34)ccc2F)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.42
KCNH2 Q12809 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
CNR1 P21554 3/20 0.37
CNR2 P34972 3/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
DRD2 P14416 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
HTR7 P34969 1/20 0.37
HRH1 P35367 1/20 0.37
ADRA1B P35368 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2278467 0.92 HTR6 (0.41) HTR6KCNH2HTR2AHTR2CCYP3A4
SCHEMBL2224695 0.92 HTR6 (0.41) HTR6KCNH2HTR2AHTR2CCNR1
SCHEMBL2271717 0.91 HTR6 (0.41) HTR6KCNH2HTR2AHTR2CCNR1
SCHEMBL2226307 0.90 KCNH2 (0.49) HTR6KCNH2HTR2AHTR2CCNR1
SCHEMBL2276442 0.89 KCNH2 (0.47) HTR6KCNH2CYP3A4HTR1AHTR1D
SCHEMBL2223438 0.85 MAPT (0.53) HTR6KCNH2HTR2AHTR2CCYP3A4
SCHEMBL2222129 0.85 HTR6 (0.46) HTR6IDH2JAK2
SCHEMBL2224849 0.84 CYP3A4 (0.43) HTR6KCNH2HTR2AHTR2CCDK2
SCHEMBL2226702 0.81 KCNH2 (0.45) HTR6KCNH2CYP3A4HTR1AHTR1D
SCHEMBL2223411 0.81 KCNH2 (0.49) HTR6KCNH2HTR2AHTR2CCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A HTR6 1/4885KCNH2 2828/4885HTR2A 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.